137 related articles for article (PubMed ID: 31411519)
1. The Efficacy of Posterior Subtenon Triamcinolone Acetonide Injection in Treatment of Irvine-Gass Syndrome.
Erden B; Çakır A; Aslan AC; Bölükbaşı S; Elçioğlu MN
Ocul Immunol Inflamm; 2019; 27(8):1235-1241. PubMed ID: 31411519
[No Abstract] [Full Text] [Related]
2. Comparison of the efficacy and safety of different methods of posterior subtenon injection.
Venkatesh P; Kumar CS; Abbas Z; Garg S
Ocul Immunol Inflamm; 2008; 16(5):217-23. PubMed ID: 19065416
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
4. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
5. SPONTANEOUS CLOSURE OF A FULL-THICKNESS MACULAR HOLE SECONDARY TO IRVINE-GASS SYNDROME.
Llop SM; Gonzalez E; Emanuelli A
Retin Cases Brief Rep; 2017 Summer; 11(3):243-245. PubMed ID: 27243783
[TBL] [Abstract][Full Text] [Related]
6. Posterior subtenon injection of triamcinolone acetonide after phacoemulsification in a patient with X-linked retinoschisis.
Wang JK; Lin WC
Optom Vis Sci; 2013 Oct; 90(10):e274-7. PubMed ID: 23974665
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema.
Yüksel B; Uzunel UD; Kerci SG; Sağban L; Küsbeci T; Örsel T
Ocul Immunol Inflamm; 2017 Aug; 25(4):513-519. PubMed ID: 27015572
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy and safety of subconjunctival triamcinolone acetonide injections in treatment of uveitic macular edema].
Liu X; Wang M; Zhao C; Gao F; Zhang M
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):734-8. PubMed ID: 26693767
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Analysis of Uveitis Macular Edema in Multiple Sclerosis Patients Receiving Deep Posterior Sub-Tenon Triamcinolone Acetonide Injection.
Jovanović S; Šarenac Vulović T; Radotić F; Tončić Z; Živković M; Petrović N
Ophthalmic Res; 2017; 58(1):1-7. PubMed ID: 28324879
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.
Karasu B
Int Ophthalmol; 2020 Mar; 40(3):677-687. PubMed ID: 31773389
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.
Tewari HK; Sony P; Chawla R; Garg SP; Venkatesh P
Eur J Ophthalmol; 2005; 15(5):619-26. PubMed ID: 16167293
[TBL] [Abstract][Full Text] [Related]
12. Phase II/III Clinical Trial of Sub-Tenon Injection of Triamcinolone Acetonide (WP-0508ST) for Diabetic Macular Edema.
Ogura Y; Shimura M; Iida T; Sakamoto T; Yoshimura N; Yamada M; Ishibashi T
Ophthalmologica; 2019; 241(3):161-169. PubMed ID: 30176671
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.
Choudhry S; Ghosh S
Clin Exp Ophthalmol; 2007 Nov; 35(8):713-8. PubMed ID: 17997773
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
15. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
Yu SY; Nam DH; Lee DY
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
17. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
Grenga P; Lupo S; Domanico D; Vingolo EM
Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
[TBL] [Abstract][Full Text] [Related]
19. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
20. Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
Ohira A; Hara K; Jóhannesson G; Tanito M; Ásgrímsdóttir GM; Lund SH; Loftsson T; Stefánsson E
Acta Ophthalmol; 2015 Nov; 93(7):610-5. PubMed ID: 26201996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]